Funding Details
- Awarder
- RSS - techcrunch.com
- Date Award
- August 02, 2024
- Vertical
- Biotech and Health
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2014
- Traction
- Healx has previously secured investigational new drug (IND) approval from the U.S. FDA for fragile X syndrome and is in the early AI-discovery or preclinical stages for a number of other conditions spanning oncology, renal, and neurology.
- Organizations Involved
- Children’s Tumor Foundation
- Founders
- Tim Guilliams, David Brown
- Company Description
- Healx is a rare disease biotechnology company that uses generative AI for drug discovery.
- Market
- Rare Diseases
- Location
-
Cambridge,
UK
- Coinvestors
- Atomico, R42, Ayana Capital, Balderton, Btov, Global Brain, Jonathan Milner, O2h, VU Venture Partners
Links